Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.4552
+0.0004 (0.09%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Tenaya Therapeutics Stock Forecast
TNYA's stock price has decreased by -89.72% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 8.60, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 1,789.28% from the current stock price of 0.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +998.42% | Mar 31, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +1,218.10% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $15 → $5 | Buy | Maintains | $15 → $5 | +998.42% | Mar 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $18 → $9 | Strong Buy | Maintains | $18 → $9 | +1,877.15% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $5 | Strong Buy | Maintains | $18 → $5 | +998.42% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.42B
Revenue Next Year
n/a
EPS This Year
-0.72
from -1.31
EPS Next Year
-0.72
from -0.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.8M | 21.0M | 544.6M | ||
| Avg | 2.6M | 4.1M | 217.2M | ||
| Low | n/a | n/a | 49.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -98.9% | 723.5% | 13,249.0% | ||
| Avg | -99.8% | 60.0% | 5,222.5% | ||
| Low | - | - | 1,101.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.54 | -0.56 | 2.48 | ||
| Avg | -0.72 | -0.72 | 0.23 | ||
| Low | -1.23 | -1.22 | -0.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.